Indexed logomarkindexed.vc

Axon Therapies

Rebalancing heart failure with SAVM

Santa Clara, United States · Founded 2016

Biotech
Healthcare
Medical Devices
Headquarters
Santa Clara, California
Employees
11–50
Founded
2016
Business Model
B2B
Website
axontherapies.com
Last Round
Series ASep 2025
Rounds
1

About

Axon Therapies is a private medtech company founded in 2016 to bring new treatment options to heart failure patients, especially those with heart failure with preserved ejection fraction (HFpEF). The company developed the SAVM (Splanchnic Ablation for Volume Management) procedure — a catheter-based, implant-free therapy that selectively ablates the greater splanchnic nerve to restore volume balance, stop disease progression, and improve quality of life. Axon's Satera Ablation System is advancing through clinical trials including the REBALANCE-HF study, with the company headquartered in Santa Clara, California and a European office in Altrincham, UK.

Summary

Axon Therapies is a Biotech company based in Santa Clara, United States, founded in 2016. Its most recent funding was a Series A round in Sep 2025. Investors include Earlybird Venture Capital, Sante Ventures and Deerfield Management.

LinkedIn

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries ASep 2025

Investors

Earlybird Venture Capital

Lead

1 round

Sante Ventures

Lead

1 round

Deerfield Management

1 round

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Appears in

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Axon Therapies on Indexed.vc
<a href="https://indexed.vc/companies/axon-therapies"><img src="https://indexed.vc/api/badge/company/axon-therapies" alt="Axon Therapies on Indexed.vc" width="260" height="76" /></a>